- Filed
- Dec 13, 2023 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · Dec 8, 2023 | 153.11M sh |
| Cash And Equivalents | Q1 2024 · Oct 31, 2023 | $12.17K |
| Cash And Equivalents | Q1 2024 · Jul 31, 2023 | $1.3K |
| Current Liabilities | Q1 2024 · Oct 31, 2023 | $30.79K |
| Current Liabilities | Q1 2024 · Jul 31, 2023 | $6.7K |
| Total Liabilities | Q1 2024 · Oct 31, 2023 | $30.79K |
| Total Liabilities | Q1 2024 · Jul 31, 2023 | $6.7K |
| Current Assets | Q1 2024 · Oct 31, 2023 | $12.17K |
| Current Assets | Q1 2024 · Jul 31, 2023 | $1.3K |
| Total Assets | Q1 2024 · Oct 31, 2023 | $12.17K |
| Total Assets | Q1 2024 · Jul 31, 2023 | $1.3K |
| Rd Expense | Q1 2024 · Oct 31, 2023 | $0 |
| Rd Expense | Q1 2024 · Oct 31, 2022 | $26.43K |
| Shares Diluted | Q1 2024 · Oct 31, 2022 | 153.11M sh |
| Stockholders Equity | Q1 2024 · Oct 31, 2022 | −$568.23K |
| Stockholders Equity | Q1 2024 · Jul 31, 2022 | −$498.16K |
| Eps Diluted | Q1 2024 · Oct 31, 2022 | $0.00 |
| Eps Basic | Q1 2024 · Oct 31, 2022 | $0.00 |
| Sga Expense restated | Q1 2024 · Oct 31, 2022 | $4.9K |
| Net Income | Q1 2024 · Oct 31, 2022 | −$93.22K |
| Operating Income restated | Q1 2024 · Oct 31, 2022 | −$26.9K |